Lactic acidosis and bone marrow suppression due to oral hypoglycemic agents
Muller, A.J.
Journal of the American Osteopathic Association 71(12): 1093-1097
1972
ISSN/ISBN: 0098-6151 PMID: 4484007 Document Number: 49234
Document emailed within 1 workday
Related Documents
Rovelli, A.; Bonomi, M.; Murano, A.; Locasciulli, A.; Uderzo, C. 1990: Severe lactic acidosis due to thiamine deficiency after bone marrow transplantation in a child with acute monocytic leukemia Haematologica 75(6): 579-581Khaitov, R.M.; Petrov, R.V.; Idorovich, I.G.; Ataullakhanov, R.I. 1978: Regulatory role of bone marrow in immunogenesis. II. Analysis of various mechanisms of antibody genesis suppression by the bone marrow B cells in vitro Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 18-22
O'Connell, F.; Mecher, C. 1988: Heart failure and lactic acidosis associated with oral procainamide Acute Care 14-15: 350-352
Vázquez, A.; Moya, G.; Ricoy, J.R. 1970: Neurological aspects of hypoglycemic coma; hypoglycemic comas of medical origin caused by hypoglycemic agents Revista Clinica Espanola 117(2): 157-168
Qian, R. 1997: Proper use of oral hypoglycemic agents Zhonghua Nei Ke Za Zhi 36(3): 149-150
Kalapos, M.P. 1994: D-lactate, D-lactic acidosis. Biochemical review of D-lactic acid metabolism and its clinical implications Orvosi Hetilap 135(27): 1459-1465
Skillman, T.G. 1973: Present status of the oral hypoglycemic agents South Dakota Journal of Medicine 26(2): 25-29
Otto-Buczkowska, E. 1973: Use of oral hypoglycemic agents in diabetic children Polski Tygodnik Lekarski 28(24): 904-907
Davidoff, F. 1973: Oral hypoglycemic agents: the pharmacological basis of their clinical use Rhode Island Medical Journal 56(10): 409-414
Grujić, M.; Perinović, M.; Rizvanbegović, B. 1976: Oral therapy of diabetes mellitus by combination of hypoglycemic agents Medicinski Arhiv 30(3): 167-171
Pollock, S.H.; Reichbaum, M.I.; Collier, B.H.; D'Souza, M.J. 1991: Inhibitory effect of cyclosporine A on the activity of oral hypoglycemic agents in rats Journal of Pharmacology and Experimental Therapeutics 258(1): 8-12
Katsuno, T.; Miyagawa, J.-I. 2012: Therapeutic indications of incretin-related derivatives and other oral hypoglycemic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 3): 693-698
Tattersall, R.B. 1984: 25 years of diabetic treatment by oral hypoglycemic agents: successes and failures Journees annuelles de diabetologie de l'Hotel-Dieu 1984: 183-191
Aftab, M.T.; Dharamshi, H.A.; Faraz, A.; Shakeel, S.; Shakeel, O. 2017: Poor adherence with ACE inhibitors is a risk factor of CVA with oral hypoglycemic agents in diabetic patients Pakistan Journal of Pharmaceutical Sciences 30(2): 415-419
Chuang, L.M.; Lu, C.; Su, R.J.; Wu, H.P.; Tai, T.Y.; Lin, B.J. 1992: Bedtime intermediate-acting insulin in the treatment of secondary failure to oral hypoglycemic agents Journal of the Formosan Medical Association 91(2): 185-189
Colman, P.G.; Harrison, L.C.; Tait, B.D. 1985: Insulin secretion and immuno-genetic markers in diabetics with 'secondary failure' of oral hypoglycemic agents Australian and New Zealand Journal of Medicine 15(2): 209-212
Pecka, M.; Bláha, M.; Procházková, J.; Marecek, D.; Jebavý, L.; Malý, J. 1985: T and B lymphocytes in bone marrow suppression Vnitrni Lekarstvi 31(6): 560-566
Spigset, O.; Messner, T. 1993: Suppression of bone marrow after drug interaction Lakartidningen 90(22): 2138-2140
Ozsahin, H.; Fabrega, S.; Douay, L.; Barbu, V.; Gorin, N.C. 1990: Application of serum-free liquid bone marrow cultures to bone marrow purging for autologous bone marrow transplantation in acute lymphoblastic leukemia Nouvelle Revue Francaise d'Hematologie 32(5): 353-355
Vu, T.Quoc. 2019: Hypoglyceamia cases in diabetic patients with insulin and oral hypoglycemic agents: A retrospective research in a secondary health facility Jpma. Journal of the Pakistan Medical Association 69(Suppl. 2)(6): S75-S79